Literature DB >> 12045496

Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss.

Mette D Hazenberg1, Sigrid A Otto, Ferdinand W N M Wit, Joep M A Lange, Dörte Hamann, Frank Miedema.   

Abstract

We studied T cell dynamics in four patients who initially responded well to highly active antiretroviral therapy (HAART) but subsequently experienced virological failure. Maintenance of peripheral blood CD4T cell counts was associated with low levels of immune activation. Low reactivity to rebounding virus may preserve normal T lymphocyte distribution over blood and tissues and be associated with stable peripheral blood T cell numbers in virological failures to HAART.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045496     DOI: 10.1097/00002030-200206140-00013

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  4 in total

1.  Low immune activation despite high levels of pathogenic human immunodeficiency virus type 1 results in long-term asymptomatic disease.

Authors:  Shailesh K Choudhary; Nienke Vrisekoop; Christine A Jansen; Sigrid A Otto; Hanneke Schuitemaker; Frank Miedema; David Camerini
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

2.  Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis.

Authors:  Stephanie Bousheri; Candace Burke; Isaac Ssewanyana; Richard Harrigan; Jeffrey Martin; Peter Hunt; David R Bangsberg; Huyen Cao
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

3.  Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients.

Authors:  Heungsup Sung; You-Sun Jung; Young-Keol Cho
Journal:  Clin Vaccine Immunol       Date:  2009-06-17

4.  Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study.

Authors:  Janaina A S Casotti; Luciana N Passos; Fabiano J P Oliveira; Crispim Cerutti
Journal:  BMC Infect Dis       Date:  2011-11-02       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.